Table of Content

  1. Introduction
    • Definition of Parkinson's Disease Market
    • Scope of the Report
  2. Methodology
    • Executive Summary
    • Market Overview
    • Market Definition and Segmentation
  3. Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
    • Porter's Five Forces Analysis
    • PESTEL Analysis
  4. Parkinson's Disease Market, By Type:
    • Juvenile Parkinson Disease
    • Young-Onset Parkinson’s Disease
    • Idiopathic Parkinson Disease
  5. Parkinson's Disease Market, By Age:
    • Adult
    • Pediatric
  6. Parkinson's Disease Market, By Diagnosis:
    • CT Scan
    • MRI Scan
    • DaTSCAN-SPECT scan
    • PET Scan
  7. Parkinson's Disease Market, By Drug Class:
    • Carbidopa-Levodopa
    • Carbidopa-Levodopa Infusion
    • Dopamine Agonists
    • Monoamine Oxidase B Inhibitors
    • Catechol O-Methyltransferase Inhibitors
    • Anticholinergics
    • Amantadine
  8. Parkinson's Disease Market, By Geography:
    • North America
      • United States
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • Saudi Arabia
      • United Arab Emirates
      • South Africa
      • Rest of Middle East & Africa
  9. Competitive Landscape
  10. Company Profiles
    • Medtronic
      • Company Overview
      • Product Portfolio and Description
      • Key Highlights
      • Financial Overview
    • Sunovion Pharmaceuticals
    • Adamas Pharmaceuticals
    • Neurocrine Biosciences
    • Supernus Pharmaceuticals
    • Kyowa Kirin
    • AbbVie
    • Integrative Research Laboratories AB
    • Rusan Pharma
    • Annovis Bio Inc.
    • Cerevel Therapeutics
    • AMneal Pharmaceuticals
  11. Conclusion and Future Outlook
    • Appendix
    • Research Methodology
    • About the Pharmanucleus
  12. Disclaimer



Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.